Beryl Drugs Limited announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced total revenue was INR 38.072 million compared to INR 33.409 million a year ago. Operating income was INR 4.753 million compared to INR 2.309 million a year ago. Net income was INR 4.887 million compared to INR 1.735 million a year ago. Basic earnings per share from continuing operations was INR 0.96 compared to INR 0.34 a year ago. For the half year, total revenue was INR 65.088 million compared to INR 75.739 million a year ago. Operating income was INR 3.011 million compared to INR 6.160 million a year ago. Net income was INR 2.926 million compared to INR 5.161 million a year ago. Basic earnings per share from continuing operations was INR 0.58 compared to INR 1.02 a year ago.